Company intelligence
Manus
Accelerating the Transition to BioAlternatives
About Manus
Manus is the world’s leading bioalternatives scale-up platform. We work with companies across industries and value chains to accelerate the transition to bioalternatives – better performing and more sustainable versions of complex molecules traditionally sourced from plants, animals, or fossil fuels. Our platform is proven to work across scales, bridging the Valley of Death between lab and manufacturing more efficiently and more reliably to deliver the benefits of biomanufacturing, today.
Verified activity
Signals from Manus
8 published signals
Research & Knowledge
Manus and The University of Texas at Austin completed a BioMADE-sponsored program to improve product recovery in biomanufacturing by addressing a key downstream processing bottleneck.
Reported by Manus
Partnerships
Manus received an additional $15 million award to expand its partnership with HHS Administration for Strategic Preparedness and Response's Industrial Base Management and Supply Chain Office (IBMSC) to enable domestic production of shikimic acid.
Reported by Manus
Partnerships
Manus announced the construction of its Augusta BioFacility in partnership with HHS Administration for Strategic Preparedness and Response's Industrial Base Management and Supply Chain Office (IBMSC) under the Defense Production Act Title III program.
Reported by Manus
Operations & Supply
Manus is constructing a new building at its Augusta BioFacility to bring new cGMP capabilities to the site, combining biomanufacturing and flow chemistry under one roof to onshore U.S. production of artemisinin.
Reported by Manus
People
Manus has an Accounting Manager named Sandy Ellis who works at the company and helps keep the company's finances running smoothly.
Reported by Manus
Presence & Recognition
Manus announced the launch of the TeamManus initiative.
Reported by Deirdre Hicks, MAOM, PHR, SHRM-CP
Products & Services
Manus is bringing bioalternatives from the lab to commercial-scale production through a biomanufacturing platform at its Augusta BioFacility.
Reported by Manus
Presence & Recognition
Manus was recently named to The Daily Digest's Bioeconomy 500 for 2026 as the company's Founder and Chief Executive Officer, Ajikumar Parayil.
Reported by Manus